Patients with BRAF V600E-mutant metastatic colorectal cancer experience poor clinical outcomes, according to real-world data. T-DM1 Is Not Associated With Improved PFS vs Historical Controls in Pretreated HER2+ Biliary Tract Cancer ByAriana Pelosci ...
Our expert team have extensive experience of working with companies to support thein vitropharmacology characterization of lead compounds and are committed to saving you precious time and resources by providing efficient screening platforms and validated 2D and 3D models, giving you confidence in your da...
(1) nurses use vigilance to keep patients safe; (2) vigilance is incorporated into expert practice over time; (3) barriers impede nurses' abilities to be effectively vigilant; and (4) nurses expect patients and families to participate in vigilance partnerships with them because it enhances the ...
Our Life Sciences oncology solutions combine expertise, experience, and evidence with advanced consulting and analytical capabilities to help you achieve commercial success. Planning your portfolio with oncology consulting We provide disease-specific data and analysis to help prioritize your assets and optimi...
Experience, Communication May Help Oncology Nurses Learn More About TIL Therapy in Advanced Melanoma With the recent FDA approval of the first tumor-infiltrating lymphocyte (TIL) therapy for the treatment of a solid tumor—unresectable or metastatic melanoma, to be exact—...
Backed by decades of experience and a range of databases, our oncology and rare disease consulting is designed to provide the guidance you need.
Callery, M. P. et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement.Ann. Surg. Oncol.16, 1727–1733 (2009). ArticlePubMedGoogle Scholar Varadhachary, G. R. et al. Borderline resectable pancreatic cancer: definitions, management, and...
Sauter ER. Cancer prevention and treatment using combination therapy with natural compounds. Expert Rev Clin Pharmacol. 2020;13(3):265–85. ArticleCASPubMedGoogle Scholar Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127(4):679–95. ...
The Patient's Experience of Ocular Melanoma in the US: A Survey of the Ocular Melanoma Foundation Regular examination by an ocular oncologist can be difficult for patients who live far from the oncology center whereas inexpert ophthalmologists close to ... AR Afshar,M Deiner,G Allen,... - ...
Next, a medically relevant labeling expert with 7 years’ experiences in pathology annotated the non-regions of interest (Non-ROIs) which mean non-relevant regions (Supplementary Section 1.2) for PD-L1 quantification in 220 PD-L1 stained WSIs using ASAP software35. These annotations resulted in ...